Microarray Synthesis and Assembly of Gene-Length Polynucleotides
First Claim
Patent Images
1. A process for assembling a polynucleotide from a plurality of oligonucleotides comprising:
- (a) synthesizing or spotting a plurality of oligonucleotide sequences on a microarray device or bead device having a solid or porous surface, wherein a first oligonucleotide is oligo 1 and a second oligonucleotide is oligo 2 and so on, wherein the plurality of oligonucleotide sequences are attached to the solid or porous surface, and wherein the first oligonucleotide sequence has an overlapping sequence region of from about 10 to about 50 bases that is the same or substantially the same as a region of a second oligonucleotide sequence, and wherein the second oligonucleotide sequence has an overlapping region with a third oligonucleotide sequence and so on;
(b) forming complimentary oligo 1 by extending primer 1, wherein primer 1 is complimentary to oligo 1;
(c) disassociating complimentary oligo 1 from oligo 1 and annealing complimentary oligo 1 to both oligo 1 and to the overlapping region of oligo 2, wherein the annealing of complimentary oligo 1 to oligo 2 serves as a primer for extension for forming complimentary oligo 1+2;
(d) repeating the primer extension cycles of step (c) until a full-length polynucleotide is produced; and
(e) amplifying the assembled complementary full length polynucleotide to produce a full length polynucleotide in desired quantities.
2 Assignments
0 Petitions
Accused Products
Abstract
There is disclosed a process for in vitro synthesis and assembly of long, gene-length polynucleotides based upon assembly of multiple shorter oligonucleotides synthesized in situ on a microarray platform. Specifically, there is disclosed a process for in situ synthesis of oligonucleotide fragments on a solid phase microarray platform and subsequent, “on device” assembly of larger polynucleotides composed of a plurality of shorter oligonucleotide fragments.
-
Citations
34 Claims
-
1. A process for assembling a polynucleotide from a plurality of oligonucleotides comprising:
-
(a) synthesizing or spotting a plurality of oligonucleotide sequences on a microarray device or bead device having a solid or porous surface, wherein a first oligonucleotide is oligo 1 and a second oligonucleotide is oligo 2 and so on, wherein the plurality of oligonucleotide sequences are attached to the solid or porous surface, and wherein the first oligonucleotide sequence has an overlapping sequence region of from about 10 to about 50 bases that is the same or substantially the same as a region of a second oligonucleotide sequence, and wherein the second oligonucleotide sequence has an overlapping region with a third oligonucleotide sequence and so on; (b) forming complimentary oligo 1 by extending primer 1, wherein primer 1 is complimentary to oligo 1; (c) disassociating complimentary oligo 1 from oligo 1 and annealing complimentary oligo 1 to both oligo 1 and to the overlapping region of oligo 2, wherein the annealing of complimentary oligo 1 to oligo 2 serves as a primer for extension for forming complimentary oligo 1+2; (d) repeating the primer extension cycles of step (c) until a full-length polynucleotide is produced; and (e) amplifying the assembled complementary full length polynucleotide to produce a full length polynucleotide in desired quantities. - View Dependent Claims (2, 3, 4, 5)
-
-
6. (canceled)
-
7. (canceled)
-
8. (canceled)
-
9. (canceled)
-
10. (canceled)
-
11. (canceled)
-
12. (canceled)
-
13. (canceled)
-
14. (canceled)
-
15. (canceled)
-
16. (canceled)
-
17. (canceled)
-
18. (canceled)
-
19. (canceled)
-
20. (canceled)
-
21. A process for creating a mixture of oligonucleotide sequences in solution comprising:
-
(a) synthesizing in situ or spotting a plurality of oligonucleotide sequences on a microarray device or bead device each having a solid or porous surface, wherein the plurality of oligonucleotide sequences are attached to the solid or porous surface, and wherein each oligonucleotide sequence further comprises two flanking sequences, one at the 3′
end and the other at the 5′
end of each oligonucleotide, wherein each flanking sequence is from about 7 to about 50 bases and comprising a primer region and a sequence segment having a restriction enzyme cleavable site;(b) amplifying each oligonucleotide using the primer regions of the flanking sequence to form a double stranded (ds) oligonucleotides; and (c) cleaving the double stranded oligonucleotide sequences at the restriction enzyme cleavable site. - View Dependent Claims (22, 23, 24, 25, 26, 27)
-
-
28. A process for creating a mixture of oligonucleotide sequences in solution comprising:
-
(a) synthesizing in situ or spotting a plurality of oligonucleotide sequences on a microarray device or bead device each having a solid or porous surface, wherein the plurality of oligonucleotide sequences are attached to the solid or porous surface, and wherein each oligonucleotide sequence has a sequence segment having a cleavable linker moiety; (b) cleaving the oligonucleotide sequences at the cleavable linker site to cleave each oligonucleotide sequence from the microarray or bead solid surface to form a soluble mixture of oligonucleotides. - View Dependent Claims (29, 30)
-
-
31. (canceled)
-
32. (canceled)
-
33. (canceled)
-
34. (canceled)
Specification